{"transactions":[{"id":2961112,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":144963,"kind":"person","name":"Bradshaw Curt","position":1,"cik":"0001794633","reported_name":"Bradshaw Curt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2020-12-02T09:46:01.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the total shares shall vest on the first anniversary of the effective date of employment, and 1/36th of the remaining shares shall vest on a monthly basis starting on the first anniversary of the effective date of employment; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date, inclusive."}],"balance_after":250000,"derivative":{"exercise_price":7.61,"expiration_date":"2030-12-01","underlying":"Common stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-20-131373","document":"tm2037471-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465920131373/tm2037471-2_4.xml","form_type":"4"}},{"id":2970380,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":144963,"kind":"person","name":"Bradshaw Curt","position":1,"cik":"0001794633","reported_name":"Bradshaw Curt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-23T22:58:54.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":15625,"price":68.73,"value":1073906.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.16 to $69.06, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"93,750 restricted stock units previously reported have been removed from this amount of securities beneficially owned due to forfeiture."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-060047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120060047/doc4.xml","form_type":"4"}},{"id":2970379,"issuer":{"id":3472,"kind":"organization","name":"ARROWHEAD PHARMACEUTICALS, INC."},"owners":[{"id":144963,"kind":"person","name":"Bradshaw Curt","position":1,"cik":"0001794633","reported_name":"Bradshaw Curt","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-23T22:58:54.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":15625,"price":69.39,"value":1084218.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities\nExchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock\nunits."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001209191-20-060047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879407/000120919120060047/doc4.xml","form_type":"4"}}]}